- Home
- DSM vs SMTI Comparison
DSM vs SMTI Comparison
Compare DSM & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSM
- SMTI
- Stock Information
- Founded
- DSM 1989
- SMTI 1982
- Country
- DSM United States
- SMTI United States
- Employees
- DSM N/A
- SMTI N/A
- Industry
- DSM Investment Managers
- SMTI Medical/Dental Instruments
- Sector
- DSM Finance
- SMTI Health Care
- Exchange
- DSM Nasdaq
- SMTI Nasdaq
- Market Cap
- DSM 303.5M
- SMTI 288.2M
- IPO Year
- DSM N/A
- SMTI N/A
- Fundamental
- Price
- DSM $6.12
- SMTI $35.98
- Analyst Decision
- DSM
- SMTI Buy
- Analyst Count
- DSM 0
- SMTI 1
- Target Price
- DSM N/A
- SMTI $44.00
- AVG Volume (30 Days)
- DSM 161.7K
- SMTI 35.9K
- Earning Date
- DSM 01-01-0001
- SMTI 11-12-2024
- Dividend Yield
- DSM 3.97%
- SMTI N/A
- EPS Growth
- DSM N/A
- SMTI N/A
- EPS
- DSM N/A
- SMTI N/A
- Revenue
- DSM N/A
- SMTI $78,056,873.00
- Revenue This Year
- DSM N/A
- SMTI $29.95
- Revenue Next Year
- DSM N/A
- SMTI $19.68
- P/E Ratio
- DSM N/A
- SMTI N/A
- Revenue Growth
- DSM N/A
- SMTI 24.66
- 52 Week Low
- DSM $4.69
- SMTI $26.00
- 52 Week High
- DSM $6.05
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- DSM 54.78
- SMTI 52.54
- Support Level
- DSM $6.09
- SMTI $34.50
- Resistance Level
- DSM $6.18
- SMTI $37.60
- Average True Range (ATR)
- DSM 0.05
- SMTI 1.95
- MACD
- DSM 0.02
- SMTI -0.24
- Stochastic Oscillator
- DSM 71.74
- SMTI 47.24
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.